192 related articles for article (PubMed ID: 30776524)
1. Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.
Pasteur J; Favier L; Pernot C; Guerriaud M; Bernigaud C; Lepage C; Jouve JL; Isambert N; Collet E
J Allergy Clin Immunol Pract; 2019; 7(6):1894-1900. PubMed ID: 30776524
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
Leguy-Seguin V; Jolimoy G; Coudert B; Pernot C; Dalac S; Vabres P; Collet E
J Allergy Clin Immunol; 2007 Mar; 119(3):726-30. PubMed ID: 17258305
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
Enrique E; Malek T; Castelló JV; de Mateo JA
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
[No Abstract] [Full Text] [Related]
4. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
Capelle H; Tummino C; Greillier L; Gouitaa M; Birnbaum J; Ausias N; Barlesi F; Montana M
J Clin Pharm Ther; 2018 Jun; 43(3):320-326. PubMed ID: 29092096
[TBL] [Abstract][Full Text] [Related]
6. Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.
Pedraza-Nieto L; Beunza-Sola M; Rodríguez CA; Moreno E; Otero MJ
Int J Clin Pharm; 2021 Aug; 43(4):1123-1127. PubMed ID: 33937971
[TBL] [Abstract][Full Text] [Related]
7. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
Otani IM; Wong J; Banerji A
Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
[TBL] [Abstract][Full Text] [Related]
8. Allergy Evaluation of Hypersensitivity to Platinum Salts and Taxanes: A Six-Year Experience.
Pradelli J; Verdoire P; Boutros J; Frin AC; Follana P; Duquesne J; Marquette CH; Benzaquen J; Ben Hayoun M; Leroy S
J Allergy Clin Immunol Pract; 2020 May; 8(5):1658-1664. PubMed ID: 31918017
[TBL] [Abstract][Full Text] [Related]
9. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.
Caiado J; Venemalm L; Pereira-Santos MC; Costa L; Barbosa MP; Castells M
J Allergy Clin Immunol Pract; 2013; 1(5):494-500. PubMed ID: 24565621
[TBL] [Abstract][Full Text] [Related]
11. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
Pagani M; Bonadonna P; Senna GE; Antico A
Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
13. [Platinum salts hypersensitivity].
Couraud S; Planus C; Rioufol C; Mornex F
Rev Pneumol Clin; 2008 Feb; 64(1):20-6. PubMed ID: 18603175
[TBL] [Abstract][Full Text] [Related]
14. Skin testing and desensitization outcomes among platinum-sensitive oncology patients.
Mawhirt SL; Fonacier LS; Calixte R; Davis-Lorton M; Aquino MR
Ann Allergy Asthma Immunol; 2018 Apr; 120(4):437-439. PubMed ID: 29625667
[No Abstract] [Full Text] [Related]
15. Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.
Caiado J; Castells M
Curr Allergy Asthma Rep; 2015 Apr; 15(4):15. PubMed ID: 26130472
[TBL] [Abstract][Full Text] [Related]
16. A search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasms.
Piovano E; Pivetta E; Modaffari P; Martra F; Baima Poma C; Perotto S; Tripodi E; Zanfagnin V; Zola P; Ferrero A
Gynecol Obstet Invest; 2012; 74(1):21-7. PubMed ID: 22652565
[TBL] [Abstract][Full Text] [Related]
17. Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity.
Markman M; Zanotti K; Kulp B; Peterson G; Markman M
Gynecol Oncol; 2003 Jun; 89(3):514-6. PubMed ID: 12798720
[TBL] [Abstract][Full Text] [Related]
18. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions associated with platinum-containing antineoplastic agents for thoracic malignancies.
Tamiya M; Kuhara H; Hirashima T; Kondo Y; Santo M; Morishita N; Suzuki H; Sasada S; Okamoto N; Kobayashi M; Kawase I
Anticancer Res; 2011 Dec; 31(12):4525-8. PubMed ID: 22199326
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.
Taylor SE; Beck TL; Krivak TC; Zorn KK; Kelley JL; Edwards RP
Gynecol Oncol; 2014 Jul; 134(1):68-72. PubMed ID: 24769036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]